deltatrials
Completed OBSERVATIONAL NCT02542371

Use of 99mTc Tilmanocept for Imaging Arterial Inflammation

Sponsor: Havard University Center for AIDS Research

Conditions HIV
Interventions Arterial Imaging
Updated 16 times since 2017 Last updated: Apr 4, 2022 Started: Sep 30, 2015 Primary completion: Aug 31, 2021 Completion: Aug 31, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates HIV and is currently completed. Havard University Center for AIDS Research leads this study, which shows 16 recorded versions since 2015 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Aug 2017 · 6 months · monthly snapshot~Aug 2017 – ~Feb 2018 · 6 months · monthly snapshot~Feb 2018 – ~Apr 2018 · 59 days · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Sep 2019 · 12 months · monthly snapshot~Sep 2019 – ~Oct 2020 · 13 months · monthly snapshot~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~May 2022 · 5 months · monthly snapshot~May 2022 – ~Jul 2024 · 26 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 23 months · monthly snapshot

Change History

16 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. May 2022 — Jul 2024 [monthly]

    Completed

    Status: Recruiting → Completed

  4. Dec 2021 — May 2022 [monthly]

    Recruiting

  5. Jan 2021 — Dec 2021 [monthly]

    Recruiting

▶ Show 11 earlier versions

  1. Nov 2020 — Jan 2021 [monthly]

    Recruiting

  2. Oct 2020 — Nov 2020 [monthly]

    Recruiting

    Status: Enrolling By Invitation → Recruiting

  3. Sep 2019 — Oct 2020 [monthly]

    Enrolling By Invitation

  4. Sep 2018 — Sep 2019 [monthly]

    Enrolling By Invitation

  5. Jun 2018 — Sep 2018 [monthly]

    Enrolling By Invitation

  6. May 2018 — Jun 2018 [monthly]

    Enrolling By Invitation

  7. Apr 2018 — May 2018 [monthly]

    Enrolling By Invitation

    Phase: NA → None

  8. Feb 2018 — Apr 2018 [monthly]

    Enrolling By Invitation NA

  9. Aug 2017 — Feb 2018 [monthly]

    Enrolling By Invitation NA

  10. Feb 2017 — Aug 2017 [monthly]

    Enrolling By Invitation NA

  11. Jan 2017 — Feb 2017 [monthly]

    Enrolling By Invitation NA

    First recorded

Sep 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Havard University Center for AIDS Research
  • Massachusetts General Hospital
  • Navidea Biopharmaceuticals
Data source: Massachusetts General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations